Cargando…
Long term prognosis and quality of life following intensive care for life-threatening complications of haematological malignancy.
Ninety-two consecutive adult patients admitted with acute life-threatening complications of haematological malignancy were studied to determine long term outcome. The quality of life was evaluated in seven long term survivors who are currently alive more than 1 year after hospital discharge using th...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977486/ https://www.ncbi.nlm.nih.gov/pubmed/1931620 |
_version_ | 1782135271662288896 |
---|---|
author | Yau, E. Rohatiner, A. Z. Lister, T. A. Hinds, C. J. |
author_facet | Yau, E. Rohatiner, A. Z. Lister, T. A. Hinds, C. J. |
author_sort | Yau, E. |
collection | PubMed |
description | Ninety-two consecutive adult patients admitted with acute life-threatening complications of haematological malignancy were studied to determine long term outcome. The quality of life was evaluated in seven long term survivors who are currently alive more than 1 year after hospital discharge using three validated methods: the Nottingham Health Profile, the Hospital Anxiety and Depression Scale and the Perceived Quality of Life Scale. Patients were also asked whether they had returned to work, whether their daily activities were limited and whether they would be willing to undergo intensive care again under the same circumstances. The in-hospital mortality rate was 77%. Median duration of long term survival was 23 months (range 6 weeks to 8 years). Long term survival did not appear to be related to either the aetiology or the severity of the acute illness, but seemed to be determined solely by the nature and progress of the underlying malignancy. The quality of life of six of the seven long term survivors is good, while that of the other is acceptable. None of the patients reported any increased limitation of their daily activities, five had returned to full time employment and all seven stated that they would be willing to undergo intensive care again under the same circumstances. |
format | Text |
id | pubmed-1977486 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1991 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-19774862009-09-10 Long term prognosis and quality of life following intensive care for life-threatening complications of haematological malignancy. Yau, E. Rohatiner, A. Z. Lister, T. A. Hinds, C. J. Br J Cancer Research Article Ninety-two consecutive adult patients admitted with acute life-threatening complications of haematological malignancy were studied to determine long term outcome. The quality of life was evaluated in seven long term survivors who are currently alive more than 1 year after hospital discharge using three validated methods: the Nottingham Health Profile, the Hospital Anxiety and Depression Scale and the Perceived Quality of Life Scale. Patients were also asked whether they had returned to work, whether their daily activities were limited and whether they would be willing to undergo intensive care again under the same circumstances. The in-hospital mortality rate was 77%. Median duration of long term survival was 23 months (range 6 weeks to 8 years). Long term survival did not appear to be related to either the aetiology or the severity of the acute illness, but seemed to be determined solely by the nature and progress of the underlying malignancy. The quality of life of six of the seven long term survivors is good, while that of the other is acceptable. None of the patients reported any increased limitation of their daily activities, five had returned to full time employment and all seven stated that they would be willing to undergo intensive care again under the same circumstances. Nature Publishing Group 1991-11 /pmc/articles/PMC1977486/ /pubmed/1931620 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Yau, E. Rohatiner, A. Z. Lister, T. A. Hinds, C. J. Long term prognosis and quality of life following intensive care for life-threatening complications of haematological malignancy. |
title | Long term prognosis and quality of life following intensive care for life-threatening complications of haematological malignancy. |
title_full | Long term prognosis and quality of life following intensive care for life-threatening complications of haematological malignancy. |
title_fullStr | Long term prognosis and quality of life following intensive care for life-threatening complications of haematological malignancy. |
title_full_unstemmed | Long term prognosis and quality of life following intensive care for life-threatening complications of haematological malignancy. |
title_short | Long term prognosis and quality of life following intensive care for life-threatening complications of haematological malignancy. |
title_sort | long term prognosis and quality of life following intensive care for life-threatening complications of haematological malignancy. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977486/ https://www.ncbi.nlm.nih.gov/pubmed/1931620 |
work_keys_str_mv | AT yaue longtermprognosisandqualityoflifefollowingintensivecareforlifethreateningcomplicationsofhaematologicalmalignancy AT rohatineraz longtermprognosisandqualityoflifefollowingintensivecareforlifethreateningcomplicationsofhaematologicalmalignancy AT listerta longtermprognosisandqualityoflifefollowingintensivecareforlifethreateningcomplicationsofhaematologicalmalignancy AT hindscj longtermprognosisandqualityoflifefollowingintensivecareforlifethreateningcomplicationsofhaematologicalmalignancy |